|
Index of reports
> Cases resulting in other serious reactions (196)
> Cases with Platelet Count Decreased (12)
Below is the selection of adverse event reports related to Voltaren (Diclofenac) that includes cases resulting in other serious reactions where reactions include platelet count decreased.
Adverse event in 20 year old male receiving Voltaren (Diclofenac)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-07-16
Patient: 20 year old male, weighing 55.0 kg (121.0 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Drug Eruption, Disseminated Intravascular Coagulation, Pyrexia, Haematocrit Decreased, RED Blood Cell Count Decreased, Gamma-Glutamyltransferase Increased, Dermatitis Bullous, Blood Creatinine Increased, Melaena, Blister, Stevens-Johnson Syndrome, White Blood Cell Count Increased, Blood Pressure Increased, Pneumonia, Histiocytosis Haematophagic, Blood Urea Increased, Alanine Aminotransferase Increased, Life Support, Pulmonary Haemorrhage, Mucosal Erosion, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Platelet Count Decreased, Skin Erosion
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Voltaren
Dosage: unk, unk
Administration route: Oral
Indication: Pyrexia
Voltaren
Dosage: 25 mg/day
Start date: 2007-03-22
End date: 2007-03-29
Loxoprofen
Dosage: 60 mg/day
Administration route: Oral
Indication: Headache
Start date: 2007-03-28
End date: 2007-04-03
Meropen
Dosage: 1.5 g/day
Indication: Infection
Start date: 2007-03-23
End date: 2007-03-28
Other drugs received by patient: Minocycline HCL; Rocephin; Zyvox; Amikacin; Funguard
Adverse event in 20 year old male receiving Voltaren (Diclofenac)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-07-16
Patient: 20 year old male, weighing 55.0 kg (121.0 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Drug Eruption, Disseminated Intravascular Coagulation, Pyrexia, Haematocrit Decreased, RED Blood Cell Count Decreased, Gamma-Glutamyltransferase Increased, Dermatitis Bullous, Blood Creatinine Increased, Melaena, Blister, Stevens-Johnson Syndrome, White Blood Cell Count Increased, Blood Pressure Increased, Pneumonia, Histiocytosis Haematophagic, Blood Urea Increased, Alanine Aminotransferase Increased, Life Support, Pulmonary Haemorrhage, Mucosal Erosion, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Platelet Count Decreased, Skin Erosion
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Voltaren
Dosage: unk, unk
Administration route: Oral
Indication: Pyrexia
Voltaren
Dosage: 25 mg/day
Start date: 2007-03-22
End date: 2007-03-29
Loxoprofen
Dosage: 60 mg/day
Administration route: Oral
Indication: Headache
Start date: 2007-03-28
End date: 2007-04-03
Meropen
Dosage: 1.5 g/day
Indication: Infection
Start date: 2007-03-23
End date: 2007-03-28
Other drugs received by patient: Minocycline HCL; Rocephin; Zyvox; Amikacin; Funguard
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-07-16
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Drug Eruption, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Erythema, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Lymphocyte Count Decreased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Blood Urea Increased, Dyspnoea, Neutrophil Count Increased, Monocyte Count Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in 70 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-07-02
Patient: 70 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Productive Cough, Pruritus, Erythema Annulare, Pyrexia, Dermatitis, C-Reactive Protein Increased, White Blood Cell Count Increased, Pleurisy, Blood Lactate Dehydrogenase Increased, LIP Ulceration, Staphylococcal Infection, Cerebral Infarction, Aspartate Aminotransferase Increased, Insomnia, Depressed Level of Consciousness, Platelet Count Decreased, Hemiplegia, Drug Eruption, Oculomucocutaneous Syndrome, Post Procedural Complication, Culture Urine Positive, Liver Disorder, Lung Neoplasm Malignant, Pleural Effusion, White Blood Cell Count Decreased, Intercostal Neuralgia, Alanine Aminotransferase Increased, Haemorrhoids, Muscular Weakness, Rash, LIP Pain, Haematochezia, Agranulocytosis, Sepsis, Sputum Retention, Cardiac Arrest, Shock, Infection
Adverse event resulted in: death
Suspect drug(s):
Voltaren
Dosage: 25 mg/day
Indication: Wound Complication
Start date: 2006-08-24
End date: 2006-08-24
Voltaren
Dosage: 25 mg/day
Start date: 2006-09-04
End date: 2006-09-23
Voltaren
Dosage: 50 mg/day
Start date: 2006-09-17
End date: 2006-09-17
Voltaren
Dosage: 50 mg/day
Start date: 2006-09-20
End date: 2006-09-20
Voltaren
Dosage: 50 mg/day
Start date: 2006-09-21
End date: 2006-09-21
Voltaren
Dosage: 50 mg/day
Start date: 2006-09-22
End date: 2006-09-22
Tegretol
Dosage: 100 mg/day
Administration route: Oral
Indication: Wound Complication
Start date: 2006-09-22
End date: 2006-09-23
Other drugs received by patient: Amoban; Zolpidem; Rohypnol; Ubretid; Spelear; Selbex; Sennoside; Takepron; Naproxen; Aspirin; Polaramine; Aminofluid; Omepral; Cataclot; Solu-Medrol; Soldem 3A; Multivitamin Additive; Heparin Sodium; Pacil; Pansporin; Finibax; Flumarin; Perdipine; Potacol-R; Radicut; NEO-Minophagen C; LOW Molecular Dextran L; Bisolvon; Magmitt Kenei; Cercine; Phenobarbital TAB; Mobic; Loxonin; Distilled Water; Ketoprofen; Laxoberon; Rinderon-VG; Wakobital; Serum Albumin Human; Humulin 70 / 30; Ropivacaine; Aminotripa 1; Aminotripa 2
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-29
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Erythema, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Lymphocyte Count Decreased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Monocyte Count Decreased, Neutrophil Count Increased, Blood Urea Increased, Dyspnoea, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in 61 year old female receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-06-19
Patient: 61 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Thoracic Cavity Drainage, Disseminated Intravascular Coagulation, Pyrexia, Laboratory Test Abnormal, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Pleural Effusion, Blood Creatinine Increased, Oxygen Saturation Decreased, Lymphocyte Count Decreased, White Blood Cell Count Increased, Neutrophil Count Increased, Blood Urea Increased, Dyspnoea, Monocyte Count Decreased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Urine Output Decreased, Lymphocyte Stimulation Test Positive, Rash Macular, Haemoglobin Decreased, Renal Failure, Aspartate Aminotransferase Increased, Oliguria, Platelet Count Decreased, Lung Infiltration
Adverse event resulted in: life threatening event
Suspect drug(s):
Voltaren
Dosage: 37.5 mg/day
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-09
End date: 2005-11-10
Loxonin
Dosage: 60 mg, tid
Administration route: Oral
Indication: Pyrexia
Start date: 2005-11-10
End date: 2005-11-13
Dacarbazine
Dosage: 180 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Nidran
Dosage: 100 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Oncovin
Dosage: 1 mg/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-08
Feron
Dosage: 3000000 iu/day
Indication: Malignant Melanoma
Start date: 2005-11-08
End date: 2005-11-12
Other drugs received by patient: Norvasc; Towamin; Lipitor; Voglibose
Adverse event in 41 year old male receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-05-11
Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol
Adverse event in 57 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-04-20
Patient: 57 year old male
Adverse reactions / side effects: Malignant Neoplasm Progression, Platelet Count Decreased
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Interferon Alfa
Indication: Metastases TO Lung
Cimetidine HCL
Voltaren
Interleukins
Voltaren
Adverse event in 41 year old male receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-04-06
Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol
Adverse event in 41 year old male receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-03-16
Patient: 41 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Brain Death, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Calcium Increased, Pyrexia, C-Reactive Protein Increased, Brain Oedema, Blood Creatinine Increased, White Blood Cell Count Increased, Mydriasis, Brain Stem Haemorrhage, Blood Urea Increased, Dyspnoea, Urine Output Decreased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Dependence ON Respirator, Haemodialysis, Brain Stem Syndrome, Dehydration, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Other drugs received by patient: Adona; Transamin; Primperan INJ; Gaster; Glyceol
Adverse event in 41 year old male receiving Voltaren (Diclofenac)
Reported by a physician from Japan on 2007-03-05
Patient: 41 year old male
Adverse reactions / side effects: Rhabdomyolysis, Brain Stem Haemorrhage, Dehydration, Platelet Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Voltaren (Diclofenac)
Adverse event in 78 year old male receiving Voltaren (Diclofenac)
Reported by a individual with unspecified qualification from Japan on 2007-02-23
Patient: 78 year old male
Adverse reactions / side effects: Haemoglobin Decreased, Leukaemia, Intestinal Ulcer, C-Reactive Protein Increased, Myelodysplastic Syndrome, Platelet Count Decreased, White Blood Cell Count Increased
Suspect drug(s):
Voltaren (Diclofenac)
|
